Lynparza 100 mg

LYNPARZA 100 MG tablets are a pharmaceutical product used in cancer treatment. This medication is manufactured by AstraZeneca Canada Inc. and is available in packs of 60 or 120 tablets.

LYNPARZA 100 MG tablets are primarily used in the treatment of certain types of cancer. Olaparib, the active ingredient, is often prescribed for patients with specific genetic mutations. This medication is part of a broader category of drugs known as PARP inhibitors, which work by targeting enzymes involved in DNA repair. What is LYNPARZA used for? It is commonly used in the management of ovarian, breast, and other cancers where genetic mutations are present.

Common effects of LYNPARZA 100 MG tablets may include fatigue, nausea, and anemia. Some patients may experience vomiting, diarrhea, or a decrease in appetite. It is important to note that individual responses to the medication can vary, and not all users will experience these effects. Always consult a healthcare provider for personalized advice.

LYNPARZA 100 MG tablets should be handled with care and stored as directed. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. Patients should be aware of potential side effects and report any severe or persistent symptoms to their doctor. Pregnant women or those planning to become pregnant should discuss the use of this medication with their healthcare provider.

LYNPARZA 100 MG tablets may interact with other medications, including certain chemotherapy drugs and CYP inhibitors. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol consumption should be discussed with a healthcare professional, as it may affect the efficacy or safety of the medication.